Skip to main content
ChenDermatologist
ChenDermatologist
Dr. Chen Yi-Jia · Dermatology Notes
English version. Prefer Traditional Chinese? Switch to Chinese
Patient guide · Infection care Per TDA official recommendations · Updated 2026-05-04

Monkeypox (Mpox) skin-care complete guide
Lesion stages, home care, scar prevention

Mpox virus infection causes lymphadenopathy, fever, headache, myalgia, and a skin rash. Most patients recover within weeks on their own. While there is no specific antiviral (treatment is symptomatic), proper skin care reduces secondary bacterial infection, scarring, and transmission risk. This article follows the Taiwan Dermatological Association mpox skin-care guidelines.

Emergency reminder:If you have ocular involvement, severe genital or anal symptoms, inability to eat, breathing difficulty, persistent high fever, or are immunocompromised, seek immediate medical attention. This article is for home-care reference only and does not replace professional medical evaluation.

What is Mpox?

Mpox (formerly monkeypox) is caused by an orthopoxvirus related to smallpox. The 2022-onward global outbreak (Clade IIb) has been the largest, with sustained human-to-human transmission primarily through close contact (including sexual contact). Clade I is more severe and is currently spreading in parts of Africa.

Clinical Presentation

  • Incubation: 5-21 days (median 7-10 days)
  • Prodrome: fever, myalgia, lymphadenopathy (helpful distinguishing feature from smallpox)
  • Rash: macules → papules → vesicles → pustules → crusts → desquamation, often painful, may be umbilicated. Often genital / perianal / oral mucous membranes in current outbreak (vs face / palms in classic).
  • Course: 2-4 weeks total; contagious until all lesions crust and new skin forms

Diagnosis

  • Clinical + lesion swab PCR (CDC reference lab)
  • Differential: HSV, syphilis, secondary syphilis, varicella, hand-foot-mouth, molluscum
  • HIV, syphilis, gonorrhea / chlamydia screening recommended

Treatment

  • Mostly supportive: pain control (NSAIDs, opioids if severe), wound care, oral care for mucosal involvement
  • Tecovirimat (TPOXX): antiviral for severe disease, immunocompromised, pregnant, pediatric, mucosal severe involvement (compassionate use program)
  • Brincidofovir, vaccinia immune globulin: severe / refractory cases
  • Vaccination: JYNNEOS (MVA-BN) — 2-dose, both pre-exposure (high-risk groups) and post-exposure (within 4-14 days)

Skin Care During Mpox

  • Keep lesions clean and dry; avoid scratching to prevent secondary bacterial infection
  • Topical antiseptics (chlorhexidine, povidone-iodine) for crusted areas
  • Topical antibiotic (mupirocin) if signs of bacterial superinfection
  • Cover lesions when possible to reduce transmission
  • Manage post-inflammatory hyperpigmentation / scarring after resolution: sunscreen, time, scar care

Prevention & Isolation

  • Avoid close skin-to-skin contact with confirmed cases until fully crusted and healed
  • Don't share bedding, towels, clothing
  • Wash hands; use PPE for healthcare workers
  • JYNNEOS vaccine for high-risk groups (sexual networks with confirmed exposure, MSM with multiple partners, healthcare workers)
  • Notify close contacts; help them seek post-exposure prophylaxis if eligible

Summary

Mpox is mostly self-limiting in healthy adults but can be severe in immunocompromised, pregnant, and pediatric patients. Early recognition, isolation, and skin care prevent secondary infection and limit transmission. Vaccination is highly effective for high-risk groups and post-exposure.